Medline CEO has 2,370 shares withheld for taxes
Medline Inc. director and Chief Executive Officer James M. Boyle reported a routine tax-related share disposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Medline Inc. director and Chief Executive Officer James M. Boyle reported a routine tax-related share disposition. The filing shows that 2,370 shares of Class A Common Stock were withheld at $36.61 per share to cover his tax liability linked to vesting restricted stock units. After this non-market transaction, Boyle directly holds 29,369 shares of Medline Inc. common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A Common Stock | 2,370 | $36.61 | $87K |
Footnotes (1)
- F1. Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
transaction code "F" regulatory
Class A Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medline Inc. (MDLN) report for James M. Boyle?
What does transaction code “F” mean in the Medline (MDLN) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.